GABAB receptor agonist baclofen improves methamphetamine-induced cognitive deficit in mice

European Journal of Pharmacology

Volumn 602, Issue 1, 2009, Pages 101-104

  Arai, Sawako ^a   Takuma, Kazuhiro ^a   Mizoguchi, Hiroyuki ^a,b   Ibi, Daisuke ^a   Nagai, Taku ^c   Kamei, Hiroyuki ^d   Kim, Hyoung Chun ^e   Yamada, Kiyofumi ^a,c,f  

^a Graduate School of Natural Science and Technology   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d Graduate School of Pharmaceutical Sciences   (Japan)

^e Kangwon National University   (South Korea)

^f JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Baclofen; Cognitive deficit; Methamphetamine; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; BACLOFEN; GABOXADOL; METHAMPHETAMINE; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; DRUG RECEPTOR BINDING; MALE; MEMORY DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; ANIMAL; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG EFFECT; INSTITUTE FOR CANCER RESEARCH MOUSE; MEMORY; PATHOPHYSIOLOGY; TIME;

ANIMALS; BACLOFEN; COGNITION DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; GABA AGONISTS; MALE; MEMORY; METHAMPHETAMINE; MICE; MICE, INBRED ICR; SCHIZOPHRENIA; TIME FACTORS;

EID: 57249108189     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.10.065     Document Type: Article

References (26)

1. Arai S., Takuma K., Mizoguchi H., Ibi D., Nagai T., Takahashi K., Kamei H., Nabeshima T., and Yamada K. Involvement of pallidotegmental neurons in methamphetamine- and MK-801-induced impairment of prepulse inhibition of the acoustic startle reflex in mice: reversal by GABA(B) receptor agonist baclofen. Neuropsychopharmacology 33 (2008) 3164-3175
2. Bartholini G. GABA receptor agonists: pharmacological spectrum and therapeutic action. Med. Res. Rev. 5 (1985) 55-75
3. B agonist baclofen blocks the expression of sensitisation to the locomotor stimulant effect of amphetamine. Behav. Pharmacol. 15 (2004) 397-401
4. Bartoletti M., Gubellini C., Ricci F., and Gaiardi M. Baclofen blocks the development of sensitization to the locomotor stimulant effect of amphetamine. Behav. pharmacol. 16 (2005) 553-558
5. Benes F.M., and Berretta S. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology. 25 (2001) 1-27
6. Brebner K., Ahn S., and Phillips A.G. Attenuation of d-amphetamine self-administration by baclofen in the rat: behavioral and neurochemical correlates. Psychopharmacology (Berl). 177 (2005) 409-417
7. B receptor agonists for the treatment of drug addiction: a review of recent findings. Drug. Alcohol. Depend. 65 (2002) 209-220
8. Cretzmeyer M., Sarrazin M.V., Huber D.L., Block R.I., and Hall J.A. Treatment of methamphetamine abuse: research findings and clinical directions. J. Subst. Abuse. Treat. 24 (2003) 267-277
9. Elvevåg B., and Goldberg T.E. Cognitive impairment in schizophrenia is the core of the disorder. Crit. Rev. Neurobil. 14 (2000) 1-21
10. B receptor-mediated modulation of the firing pattern of ventral tegmental area dopamine neurons in vivo. Naunyn-Schmiedeberg's Arch. Pharmacol. 365 (2002) 173-180
11. B drugs on working memory in C57BL/6J and DBA/2J mice. Psychopharmacology (Berl) 176 (2004) 166-174
12. Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia? Am. J. Psychiatry. 153 (1996) 321-330
13. Mizoguchi H., Takuma K., Fukakusa A., Ito Y., Nakatani A., Ibi D., Kim H.C., and Yamada K. Improvement by minocycline of methamphetamine-induced impairment of recognition memory in mice. Psychopharmacology (Berl) 196 (2008) 233-241
14. Kalechstein A.D., Newton T.F., and Green M. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. J. Neuropsychiatry Clin. Neurosci. 15 (2003) 215-220
15. Kamei H., Nagai T., Nakano H., Togan Y., Takayanagi M., Takahashi K., Kobayashi K., Yoshida S., Maeda K., Takuma K., Nabeshima T., and Yamada K. Repeated methamphetamine treatment impairs recognition memory through a failure of novelty-induced ERK 1/2 activation in the prefrontal cortex of mice. Biol. Psychiatry 59 (2006) 75-84
16. Lee M.A., Jayathilake K., and Meltzer H.Y. A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia. Schizophr. Res. 37 (1999) 1-11
17. Lewis D.A. GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia. Brain Res. Brain Res. Rev. 31 (2000) 270-276
18. Nagai T., Takuma K., Dohniwa M., Ibi D., Mizoguchi H., Kamei H., Nabeshima T., and Yamada K. Repeated methamphetamine treatment impairs spatial working memory in rats: reversal by clozapine but not haloperidol. Psychopharmacology (Berl) 194 (2007) 21-32
19. Nordahl T.E., Salo R., and Leamon M. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review. J. Neuropsychiatry Clin. Neurosci. 15 (2003) 317-325
20. Rawson R.A., Gonzales R., and Brethen P. Treatment of methamphetamine use disorders: an update. J. Subst. Abuse. Treat. 23 (2002) 145-150
21. Simon S.L., Domier C., Carnell J., Brethen P., Rawson R., and Ling W. Cognitive impairment in individuals currently using methamphetamine. Am. J. Addic. 29 (2000) 222-231
22. Srisurapanont M., Ali R., Marsden J., Sunga A., Wada K., and Monteiro M. Psychotic symptoms in methamphetamine psychotic in-patients. Int. J. Neuropsychopharmacol. 6 (2003) 347-352
23. Tepper J.M., and Lee C.R. GABAergic control of substantia nigra dopaminergic neurons. Prog. Brain Res. 160 (2007) 189-208
24. Westerink B.H., Kwint H.F., and deVries J.B. The pharmacology of mesolimbic dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and nucleus accumbens of the rat brain. J. Neurosci. 16 (1996) 2605-2611
25. Xi Z.X., Ramamoorthy S., Shen H., Lake R., Samuvel D.J., and Kalivas P.W. GABA transmission in the nucleus accumbens is altered after withdrawal from repeated cocaine. J. Neurosci. 28 (2003) 3498-3505
26. Yui K., Ikemoto S., Goto K., Nishijima K., Yoshino T., and Ishiguro T. Spontaneous recurrence of methamphetamine-induced paranoidhallucinatory states in female subjects: Susceptibility to psychotic states and implications for relapse of schizophrenia. Pharmacopsychiatry 35 (2002) 62-71